What Researchers Did
Researchers retrospectively analyzed data from 706 adult patients with carbon monoxide poisoning treated with hyperbaric oxygen therapy (HBO2) to compare neurocognitive outcomes based on treatment delay intervals.
What They Found
At 6 months, the early HBO2 group (≤6 hours) had significantly fewer patients with poor neurocognitive outcomes compared to the late group (6-24 hours, p = 0.027). Specifically, the early group showed significantly better outcomes than those treated between 6-12 hours (p = 0.033) and 12-24 hours (p = 0.004) at 6 months, with poor prognoses increasing with treatment delay (p = 0.008).
What This Means for Canadian Patients
Canadian patients experiencing carbon monoxide poisoning may benefit from receiving hyperbaric oxygen therapy as soon as possible, ideally within 6 hours, to improve neurocognitive outcomes. Prompt medical attention and rapid access to HBO2 facilities could be crucial for reducing long-term neurological complications.
Canadian Relevance
This study was conducted in the Republic of Korea and has no direct Canadian connection.
Study Limitations
A limitation of this study is its retrospective design and reliance on data from a single academic medical center.